Aurobindo Pharma Limited (Aurobindo) announced that its subsidiary CuraTeQ Biologics Pvt Ltd. (CuraTeQ) has expanded the scope of its marketing and distribution agreement with Orion Corporation (Orion) to commercialize its biosimilars pipeline to include the Baltic states in Europe. Earlier in 2020, CuraTeQ and Orion had entered into a licensing agreement, granting marketing and distribution…